DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20205216

Prevalence and determinants of anemia amongst HIV positive pregnant women in a tertiary Hospital in Nigeria

Innocent O. Eze, Clara U. Innoeze, Malachy E. Ayogu, Stephen C. Eze

Abstract


Background: In pregnancy, anemia is associated with increased risk of both maternal and fetal morbidity and mortality especially in HIV situation. To determine the prevalence and determinants of anemia in HIV positive compared to HIV negative women.

Methods: This was a cross sectional study carried out from June 2016 to December 2017 amongst pregnant women who presented to the antenatal clinic. Information on socio-demographic variables and laboratory test to determine the hemoglobin levels and CD4 count (for the HIV positive women) were carried out. A total of 350 subjects with equal number of HIV positive and HIV negative pregnant women were recruited. Variables were compared between the two groups using software package for social sciences version 20. P values<0.05 at 95% confidence interval are considered statistically significant.

Results: The mean age for HIV positive and negative were 31.54 ±4.1 and 29.03 respectively while, mean gestational age at booking for HIV positive and negative were 20.41±8.61 and 22.37±7.4 weeks respectively. The HIV positive group had a mean parity of 2.02±1.5, and 2.56±1.2 was that of the HIV negative group. The mean hemoglobin statuses at booking were 9.92±1.8 g/dl and 10.6±1.1 g/df HIV positive and HIV negative women respectively. The mean CD4+ at booking for HIV positive group was 478±251 per microliter. The overall prevalence of anemia irrespective of HIV status was 36.6%. The prevalence of anemia in HIV positive and negative women were 44.6% and 28.6% respectively. There was statistically significant relationship between anemia and HIV status (p=0.002).

Conclusions: There was inverse relationship between CD4+ count and anemia. Low CD4+ count and non-use of HAART at booking were important determinants of anemia among the HIV.


Keywords


Anemia, CD4+, Determinants, HIV, Prevalence, Nigeria

Full Text:

PDF

References


Wondimeneh F. Prevalence and related factors of anemia in HAART-naive HIV positive patients at Gondar University Hospital, Northwest Ethiopia. Brit Med Centr Hematol. 2013;13:8.

Uneke CJ, Duhlinska DD, Igbinedion EB. Prevalence and Public-health Significance of HIV Infection and Anemia among PregnantWomen Attending Antenatal Clinics in South-eastern Nigeria. J Health Popul Nutr. 2007;(3):328-35

Shayikh SS, I, Zahid Z, Mohd MK, Sarfraz K. An Overview of Anemia in Pregnancy. J Inn Pharm and Bio Sci. 2015;2(2):144-51

Munyazesa E, Emile I, Mutimura E. Assessment of hematological parameters in HIV-infected and uninfected Rwandan women: Across-sectional study. Brit Med J O. 2012;2:e001600.

Mulambalah CS, Siamba DN, Ogutu PA, Siteti DI, Wekesa AW. Anemia in pregnancy: Prevalence and possible risk factors in Kakamega County, Kenya Sci J Pub Heal. 2014;2(3):216-22.

Stephen G, Mgongo M, Hashim TU, Katanga J, Stray-Perdesen B, Msuya SE. Anemia in Pregnancy: Prevalence, Risk Factors, and Adverse Perinatal Outcomes in Northern Tanzania. Hinda Anem. 2018.

Dairo MD, Lawoyin TO, Onadeko MO, Asekun, Olarinmoye EO, Adeniji AO. HIV as an additional risk factor for anemia in pregnancy: evidence from primary care level in Ibadan, South Western Nigeria. Afr J Med Sci. 2005;34(3):275-9.

UNAIDS report on the global AIDS Epidemic. Geneva: UNAIDS, 2012.

Obirikorang C, Yeboah FA. Blood hemoglobin measurements as a predictive indicator for the progression of HIV/AIDS in resource-limited setting. J Biomed Sci. 2009;16:102.

Mildvan D, Creagh T, Leitz G. The anemia prevalence study group: Prevalence of anemia and correlation with biomarkers and specific anti-retroviral regimens in 9690 human immune deficiency virus infected patients. Curr med res opin. 2007;23(2):343-55.

Mata-Marín JA, Gaytán-Martínez JE, Martínez-Martín RE. Risk factors and correlates for anemia in HIV treatment-naïve infected patients: a cross-sectional analytical study. Brit Med Centr Res Not. 2010;3:230.

World Health Organization. Nutritional Anemia. World Health Organ. Tch ref ser. 1972;503.

Okunade KS, Adegbesan-Omilabu MA. Anemia among pregnant women at the booking clinic of a Teaching Hospital in South-western Nigeria. Int J of Med Biomed Resea. 2014;3(2):114-20.

Lawson RJ. Anemia in pregnancy. In: Lawson JB, Steward (Ed). Obstetrics and Gynecology in Tropics and developing countries. Edward Arnold Publ. 1983:73-9.

Harrison KA. Anemia in pregnancy. In: Lawson JB, Harrison KA, Bergsrom S (editors). Maternity Care in Developing countries. Roy Colle Obstet Gynaecol Press. 2000:2-128.

Ogunbode O. Anaemiainpregnacy In: Okonofua F, Odunsi K(Ed). Contemporary Obstetrics and Gynaecology for Developing countries. Women’s Health and Action Research Centre. 2003:515-29.

Okeudo C, Ezem BU, Ojiyi EC, Anolue FC, Dike EI. Prevalence of anemia among HIV positive pregnant women at booking in Orlu, South-Eastern Nigeria: Afri Medic J. 2014;5(1):45-9.

Olatunbosun OA, Abasiattai AM, Bassey EA, James RS, Ibanga G, Morgan A. Prevalence of anaemia among pregnant women at booking in the University of Uyo Teaching Hospital, Uyo, Nigeria. Bio Med Resea Int. 2014;2014.

Adesina O, Oladokun A, Akingbola T, Awolude O, Adewole I. Risk of anemia in HIV positive pregnant women in Ibadan, south west Nigeria. Afr J Med Sci. 2011;40(1):67-73

Ohihoin AG, Musa J, Sagay AS, Uja IAO, Herberston EC, Ocheke A. Prevalence and determinants of anemia among HIV positive pregnant women attending ante-natal clinic at Jos University Teaching Hospital, Jos North Central Nigeria: BJM and Med research. 2014;4(34):5348-56.

Idowu OA, Mafiana CF, Sotiloye D. Anemia in pregnancy: A survey of pregnant women in Abeokuta Nigeria. Afr Health Sci. 2005;5(4):295-9.

Olusanya O, Okpere E, Ezimokhai M. The importance of social class in fertility control in a developing country. W Afric J Medic. 1985;4:205-12.

Grztchen A, Gernald I. Msamango, Donna S, Ernest JN, Urassa et al. Nutritional factors and infectious disease contribute to anemia among pregnant women with Human Immuno Deficiency Virus in Tanzania. J Nutrit. 2002;130:19050-57.

Ndukwu GU, Dienye PO. Prevalence and socio-demographic factors associated with anaemia in pregnancy in a primary health center in Rivers state, Nigeria. Afr J Prm Heal Car Fam Med. 2012;4(1):1-7.

Ajayi AO, Ajayi EA, Fasakin KA. CD4+ T-lymphocytes cell counts in adults with human immunodeficiency virus infection at the medical department of a tertiary health institution in Nigeria. Ann Afr Med. 2009;8:257-60.

Moyle G. Anemia in persons with HIV infection: prognostic marker and contribution to morbidity. AIDS Rev. 2002;4(1):13-20.

Willis TS, Nadler JP, Somboowit C, Vincent A, Leitz G, Marino et al. Anemia prevalence and associated risk factors in a single centre ambulatory HIV clinical cohort. Aids read, 2004;14(6):3014-5.

Ibrahim A, Yahaya H, Gwarzo MY, Muhammad AB, Sharfadi RS. Anaemia and Immunological Markers in HIV Patients on Antiretroviral Drugs (HAART). O Sci J Clinic Medic. 2015;30(2):42-6.

Deresse D, Dereje L, Aderajew A. Prevalence of anemia before and after the initiation of antiretroviral therapy at ART Centre of Hawassa University Referral Hospital, Hawassa, South Ethiopia. Schol J Medic. 2013;3(1):1-6.

Paul AV, Alexandra ML, Douglas D, Donna M, Ronald M, and Michael S. Anemia in HIV Infection: Clinical Impact and Evidence-Based Management Strategies: Anemia in HIV Working Group; the Infectious Diseases Society of America, 2014.